Therapeutic Implications of Microglia Activation by Lipopolysaccharide and Reactive Oxygen Species Generation in Septic Shock and Central Nervous System Pathologies: A Review

Medicina

Volumn 58, Issue 4, 1998, Pages 377-385

  Mayer, Alejandro M S ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Lipopolysaccharide; Microglia; Reactive oxygen species; Review; Sepsis; Shock; Superoxide; Therapy

Indexed keywords

ANTIOXIDANT; AUTACOID; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASE; HAMSTER; METABOLISM; MICROGLIA; MOUSE; PHYSIOLOGY; RAT; REVIEW; SEPTIC SHOCK;

ANIMALS; ANTIOXIDANTS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASES; CRICETINAE; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; RATS; REACTIVE OXYGEN SPECIES; SHOCK, SEPTIC;

EID: 0032247701     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (137)

1. Arrigoni LE, Rogers DK. Intensive Care Therapeutics. In: Young LY, Koda-Kimble MA, (eds). Applied Therapeutics: The clinical use of drugs. Vancouver:Applied Therapeutics, Inc., 1995; 1802-35.
2. Deitch EA. Animal models of sepsis and shock: a review and lessons learned. Shock 1998: 1: 1-11.
3. Bowton DL. CNS effects of sepsis. Crit Care Clin 1989; 5. 785-92.
4. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in Adults. Clinic Infec Dis 1997, 24: 584-602.
5. Lavoie FW. Meningitis, encephalitis, and central nervous system abscess. In: Rosen P, Barkin R. (eds). Emergency Medicine. Concepts and Clinical Practice. St. Louis: Mosby-Year Book Inc., 1998; 2198-2211.
6. Tunkel AR Scheid WM. Pathogenesis and pathophysiology of bacterial meningitis. Annu Rev Med 1993; 44: 103-20.
7. Holst O, Ulmer AJ, Brade H, Flad HD, Rietschel ET. Biochemistry and cell biology of bacterial endotoxins. Minireview. FEMS Inmunol Med Microbiol 1996; 16: 83-104.
8. Pfeiffer R. Untersuchungen uber das Choleragift. Z Hyg Infektionskr 1892; 11: 393-412
9. Burrell R. Human responses to bacterial endotoxin. Circ Shock 1994; 43: 137-53.
10. Wright SD. Multiple receptors for endotoxin. Curr Opin Immunol 1991; 3: 83-90.
11. Pfister HW, Scheld WM. Brain injury in bacterial meningitis: therapeutic implications. Curr Opin Neurol 1997; 10: 254-59.
12. Abbott NJ, Revest PA. Control of brain endothelial permeability. Cerebrovasc Brain Metab Rev 1991; 3: 39-72.
13. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function and mechanism of action. Am J Physiol 1992; 263: C1-C16.
14. Zimmerman JJ. Oxygen free radicals. In: Chernow B (ed). The Pharmacologic approach to the critically ill patient. Williams & Wilkins. 1994; 901-25.
15. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992; 59: 1609-23.
16. Colton CA, Yao J, Gilbert D, Oster-Granite ML Enhanced production of superoxide anion by microglia from trisomy 16 mice. Brain Res 1990; 519: 236-42.
17. Chan PH. Role of oxidants in ischemic brain damage. Stroke 1996; 27: 1125-9.
18. Kontos HA. Oxygen radicals in CNS damage. Review Article. Chem Biol Interact 1989; 72: 229-55.
19. Bergeron C, Muntasser S, Somerville MJ, Weyer L, Percy ME. Copper/zinc superoxide dismutase mRNA levels are increased in sporadic amyotrophic lateral sclerosis motorneurons. Brain Res 1994; 659: 272-6.
20. Ruuls SR, Bauer J, Sontrop K, Huitinga I, Hart BA, Dijkstra CD. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 1995, 56: 207-17.
21. Deli MA, Descamps L, Dehouck MP, et al. Exposure of TNF-α to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase in permeability and cytoplasmatic stress fiber formation of actin. J Neurosci Res 1995, 41: 717-26.
22. Quagliarello VJ, Wispelwey B, Long WJ, Scheld WM. Recombinant human interteukin-1 induces meningitis and blood-brain barrier injury in the rat. J Clin Invest 1991; 87: 1360-6.
23. Rothwell NJ. Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol Sci 1991; 12: 430-6.
24. Dawson VL, Dawson TM. Nitric oxide in neuronal degeneration. Proc Soc Exp Biol Med 1996; 211: 33-40.
25. Giulian D, Baker TJ. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 1986; 6: 2163-78.
26. Colton CA, Gilbert DA. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 1987; 223: 284-8.
27. Sonderer P, Wils P, Wyler R, Fontana A, Peterhans E, Schwyzer M. Murine glial cells in culture can be stimulated to generate reactive oxygen J Leukoc Biol 1987; 42: 463-73.
28. Dwork AJ, Schon EA, Herbert J. Nonidentical distribution of transferrin and ferric iron in human brain. Neuroscience 1988; 27: 333-45.
29. 2, on synaptic transmission produced by hydrogen peroxide. J Free Rad Biol Med 1989; 7: 3-8.
30. Szuchet S, Polak P, Yim, SH. Mature oligodendrocytes cultured in the absence of neurons recapitulate the ontogenic development of myelin membranes. Dev Neurosci 1986; 8: 208-21.
31. Griot C, Vandevelde M, Richard A, Peterhans E, Stocker R. Selective degeneration of oligodendrocytes mediated by reactive oxygen species. Free Radic Res Commun 1990; 11: 181-93.
32. Fridovich I. Superoxide dismutase. Annu Rev Pharmacol Toxicol 1983; 23: 239-57.
33. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide; physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-42.
34. Byczkowski JZ, Gessner T. Biological role of superoxide ion-radical. Minireview. Int J Biochem 1988; 20: 569-80.
35. Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79: 319-26.
36. Del Rio Hortega P. In Cytology and Cellular Pathology of the Nervous System. 1932; (Penfield, W. ed.) 482-534, Paul Hoeber, New York.
37. Lassman H, Schmeid M, Vass K, Hickey WF. Bone marrow derived elements and resident microglia in brain inflammation. Glia 1993; 7: 19-24.
38. Ling EA, Wong WC. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 1993; 7: 9-18.
39. Theele DP, Streit WJ. A chronicle of microglial ontogeny. Glia 1993; 7: 5-8.
40. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW. Cytotoxicity of microglia. Glia 1993; 7: 111-8.
41. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996; 19: 312-318.
42. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993; 7: 75-83.
43. Lassmann H, Hickey WF. Dynamics of microglia in brain pathology. Clin Neuropathol 1993; 12: 284-5.
44. Gehrmann J, Matsumoto Y, Kreutzberg GW: Microglia: intrinsic immunoeffector cell of the brain. Brain Res Rev 1995; 20: 269-87.
45. Johnston RB. Monocytes and macrophages. N Engl J Med 1988; 318: 747-52.
46. Laskin DL, Pendino KJ: Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 1995; 35: 655-677.
47. McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 1995; 21: 195-218.
48. Doe WF, Yang ST, Morrison DC, Betz SJ, Henson PM. Macrophage stimulation by bacterial lipopolysaccharides. II. Evidence for differentiation signals delivered by lipid A and by a protein rich fraction of lipopolysaccharides. J Exp Med 1978; 148: 557-68.
49. Mayer AMS, Spitzer JA. Continuous infusion of Escherichia coll endotoxin in vivo primes in vitro superoxide anion release in rat polymorphonuclear leukocytes and Kupffer cells in a time-dependent manner. Infect Immun 1991; 59: 4590-8.
50. Mayer AMS, Spitzer JA. Modulation of superoxide generation in in vivo lipopolysaccharide-primed Kupffer cells by staurosporine, okadaic acid, manoalide, arachidonic acid, genistein and sodium orthovanadate. J Pharmacol Exp Ther 1994; 268: 238-247.
51. Perry VH, Gordon S. Macrophages and the nervous system. Int Rev Cytol 1991; 125: 203-44.
52. Mayer AMS, Oh S, Presto E, Glaser KB, Jacobson P. LPS-primed rat brain microglia: a convenient in vitro model to search for antiinflammatory marine natural products. Shock 1997; 7(S2). 49.
53. Wispelwey B, Lesse AJ, Hansen EJ, Scheld WM. Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. J Clin Invest 1998; 82: 1339-46.
54. Buttini M, Limonta S, Boddeke HW. Peripheral administration of lipopolysaccharide induces activation of microglial cells in rat brain. Neurochem Int 1996; 29: 25-35.
55. Andersson PB, Perry VH, Gordon S. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 1992; 48: 169-86.
56. Van Dam, AM, Brouns M, Louisse S, Berkenbosch. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness. Brain Res 1992; 588: 291-6.
57. Bell MD, Lopez-Gonzalez R, Lawson L, et al. Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS. J Neurocytol 1994; 23: 605-13.
58. Xu J, Ling EA. Upregulation and induction of surface antigens with special reference to MHC class II expressions in miroglia in postnatal rat brain following intravenous or intraperitoneal injections of lipopolysaccharide. J Anat 1994; 184: 285-96.
59. Bell MD, Perry VH. Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammagen or during acute neuronal degeneration. J Neurocytol 1995; 24: 695-710.
60. Giulian D, Baker TJ, Shih LN, Lachman LB. Interleukin-1 of the central nervous system is produced by ameboid microglia. J Exp Med 1986; 164: 594-604.
61. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A. Antigen presentation and tumor cytotoxicity by interferon γ-treated-microglial cells. Eur J Immunol 1987; 17: 1271-8.
62. Gebicke-Haerter PJ, Bauer J, Schobert A, Northoff H. Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells. J Neurosci 1989; 9: 183-94.
63. Mallat M, Houlgatte R, Brachet P, Prochianz A, Lipopolysaccharide-stimulated rat brain macrophages release NGF in vitro. Dev Biol 1989; 133: 309-11.
64. Sawada M, Kondo N, Suzumura A, Marunouchi T. Production of TNF-α by microglia and astrocytes in culture. Brain Res 1989;401: 394-7.
65. Boje KM, Arora PK. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 1992; 587: 250-6.
66. Sawada M, Suzumura A, Marunouchi T. Down regulation of CD4 expression in cultured microglia by immunosuppressants and lipopolysaccharide. Biochem Biophys Res Commun 1992; 189: 869-76.
67. Nakajima K, Shimojo M, Hamanoue M, Ishiura S, Sugita H, Kohsaka S. Identification of elastase as a secretory protease from cultured rat microglia. J Neurochem 1992; 58: 1401-8.
68. Yao J, Ken JE, Taffs RE, Colton CA. Characterization of interleukin-1 by microglia in culture. Brain Res 1992; 591: 88-93.
69. Chao CC, Hu S, Gekker G, Novick WJ, Remington JS, Peterson PK Effects of cytokines on multiplication of Toxoplasma gondii in microglial cells. J Immunol 1993; 150: 3404-10.
70. Haga S, Ikeda K, Sato M, Ishii T. Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res 1993; 601: 88-94.
71. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW. Cytokine production by human microglia and astrocytes. J Immunol 1993; 150: 2659-67.
72. 2+]i transients and changes the organization of actin in microgiia. Glia 1994; 11: 336-44.
73. Mizuno T, Sawada M, Marunouchi T, Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem Biophys Res Commun 1994; 205: 1907-15.
74. Norenberg W, Gebicke-Haerter PJ, Illes P: Voltage-dependent potassium channels in activated rat microglia. J Physiol (Lond) 1994; 475: 15-32.
75. Patrizio M, Levi G. Glutamate production by cultured microglia: differences between rat and mouse, enhancement by lipopolysaccharide and lack effect of HIV coat protein gp120 and depolarizing agents. Neurosci Lett 1994; 178: 184-8.
76. Chao CC, Gekker G, Sheng WS, Hu S, Tsang M, Peterson PK. Priming of morphine on the production of tumor necrosis factor-α by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression. J Pharmacol Exp Ther 1994; 269: 198-203.
77. Abd-El-Basset E, Fedoroff S. Effect of bacterial wall lipopoiysaccharide on morphology, motility, and cytoskeletal organization of microglia in cultures. J Neurosci Res 1995; 41: 222-37.
78. Appel K, Buttini M, Sauter A, Gebicke-Haerter PJ. Cloning of rat interleukin-3 receptor β-subunit from cultured microglia and its mRNA expression in vivo. J Neurosci 1995; 15: 5800-5809.
79. Gottschall PE, Yu X, Bing B. Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. J Neurosci Res 1995; 42: 335-42.
80. Hayashi M, Luo Y, Laning J, Strieter RM, Dorf ME. Production and function of monocyte chemoattractant protein-1 and other β-chemokines in murine glial cells. J Neuroimmunol 1995; 60: 143-50.
81. Kim YS, Kennedy S, Tauber MG. Toxicity of Streptococcus pneumoniae in neurons, astrocytes, and microglia in vitro. J Infec Dis 1995; 171: 1363-8.
82. Minghetti L, Levi G. Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures. J Neurochem 1995; 65: 2690-8.
83. Patrizio M, Costa T, Levi G. Interferon-γ and lipopolysaccharide reduce cAMP responses in cultured glial cells: reversal by a type IV phosphodiesterase inhibitor. Glia 1995; 14: 94-100.
84. Ryan RE, Sloane BF, Sameni M, Wood PL. Microglial cathepsin B: an immunological examination of cellular and secreted species. J Neurochem 1995; 65: 1035-45.
85. Sakai N, Kaufman S, Milstien S. Parallel induction of nitric oxide and tetrahydrobiopterin synthesis by cytokines in rat glial cells. J Neurochem 1995; 895-902.
86. Sawada M, Suzumura A, Marunouchi T. Induction of functional interleukin-2 receptor in mouse microglia. J Neurochem 1995; 64: 1973-9.
87. Walker DG, Kim SU, McGeer PL. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J Neurosci Res 1995; 40: 478-93.
88. Fincher IV EF, Johannsen L, Kapas L, Takahashi S, Krueger JM. Microglia digest Staphylococcus aureus into low molecular weight biologically active compounds. Am J Physiol 1996; 271: R149-R156.
89. Lodge PA, Sriram S. Regulation of microglia activation by TGF-β, IL-10, and CSF-1. J Leukoc Biol 1996; 60: 502-508.
90. Zhang SC, Fedoroff S. Neuron-microglia interactions in vitro. Acta Neuropathol 1996; 91: 385-95.
91. 2 and cAMP-elevating agents. J Neuroimmunol 1997, 72: 83-93.
92. Zuckerman SH, Gustin J, Evan GF. Expression of CD54 (Intercellular adhesion molecule-1) and the β1 integrin CD29 is modulated by a cyclic AMP dependent pathway in activated primary rat microglial cell cultures. Inflammation 1998; 22: 95-106.
93. Mayer AMS, Oh S, Ramsey KH, Romanic A. Escherichia coli lipopolysaccharide appears to induce apoptosis in rat brain microglia. Soc Neurosci Abstr 1998 (in press)..
94. Yoshida T, Tanaka M, Sotomatsu A, Hirai S. Activated microglia cause superoxide-mediated release of iron from ferritin. Neurosci Lett 1995; 190: 21-4.
95. Woodroofe MN, Hayes GM, Cuzner ML. Fc receptor density, MHC antigen expression and superoxide production are increased in interferon-gamma-treated microglia isolated from adult brain. Immunology 1989; 68: 421-6.
96. Burge T, Griot C, Vandevelde M and Peterhans E. Antiviral antibodies stimulate production of reactive oxygen species in cultured canine brain cells infected with canine distemper virus. J Virol 1989; 63: 2790-7.
97. Suzumura A, Marunouchi T, Yamamoto H. Morphological transformation of microglia in vitro. Brain Res 1991; 545: 301-6.
98. Piani D, Spranger M, Frei K, Schaffner A, Fontano A. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor postive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol 1992; 22: 2429-36.
99. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992; 149: 2736-41.
100. Colton CA, Yao J, Keri JE, Gilbert D. Regulation of microglial function by interferons. J Neuroimmunol 1992; 30: 89-98.
101. Zielasek J, Tausch M, Toyka KV, Hartung HP. Production of nitrite by neonatal rat microglial cells/brain macrophages. Cell Immunol 1992; 141: 111-20.
102. Banati RB, Schubert P, Rothe G, et al. Modulation of intracellular formation of reactive oxygen intermediates in peritoneal macrophages and microglia/brain macrophages by propentofylline. J Cereb Blood Flow Metab 1994; 14: 145-9.
103. Corradin SB, Mauel J, Donini SD,Quattrocchi E, Ricciardi-Castagnoli P inducible nitric oxide synthase activity of cloned murine microglial cells. Glia 1993; 7: 255-62.
104. Klegeris A, McGeer PL. Rat brain microglia and peritoneal macrophages show similar responses to respiratory burst stimulants. J Neuroimmunol 1994; 53: 83-90.
105. 2+ channels. Am J Physiol 1994; 266: C1650-C1655
106. Colton CA, Snell J, Chernyshev O, Gilbert DL. Induction of superoxide anion and nitric oxide production in cultured microglia. Ann N Y Acad Sci 1994; 738: 54-63.
107. Chao CC, Hu S, Peterson PK. Modulation of human microglial superoxide production by cytokines. J Leukoc Biol 1995; 58: 65-70.
108. Hu S, Chao CC, Khanna KV, Gekker G, Peterson PK, Molitor TW. Cytokine and free radical production by porcine microglia. Clin Immunol Immunopathol 1996; 78: 93-6.
109. Ii M, Sunamoto M, Ohnishi K, Ichimori Y. β-amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res 1996; 720: 93-100.
110. 2a production in human microglial cells but not in astrocytes. J Immunol 1996; 157: 2129-35.
111. Mohan PF, Ard MD. Induction of microglial nitric oxide synthesis by very low density lipoprotein. Glia 1996; 17: 259-62.
112. Mosley K, Cuzner ML. Receptor-mediated phagocytosis of myelin by macrophages and microglia: effect of opsonization and receptor blocking agents. Neurochem Res 1996; 21: 481-7.
113. Van Muiswinkel FL, Veerhuis R, Eikelenboom P. Amyloid â protein primes cultured rat microglial cells for enhanced phorbol 12-myristate 13-acetate-induced respiratory burst activity. J Neurochem 1996; 66: 2468-76.
114. Colton C, Wilt S, Gilbert D, Chemyshev O, Snell J, Dubois-Dalq M. Species differences in the generation of reactive oxygen species by microglia. Mol Chem Neuropathol 1996; 28: 15-20.
115. Si QS, Nakamura Y, Kataoka K. Albumin enhances superoxide production in cultured microglia. Glia 1997; 21: 413-8.
116. Si QS, Nakamura Y, Kataoka K. Hypothermic suppression of microglial activation in culture: inhibition of cell proliferation and production of nitric oxide and superoxide. Neuroscience 1997; 81: 223-9.
117. Murata JI, Castagnoli P, Mange P, Martin F, Jeanneret LJ: Microglial cells induce cytotoxic effects toward colon carcinoma cells: measurement of tumor cytotoxicity with a ā-glutamyl transpeptidase assay. Int J Cancer 1997; 70: 169-74.
118. Klegeris A, McGeer PL β-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J Neurosci Res 1997; 49: 229-35.
119. Ding M, St. Pierre BA, Parkinson JF, et al, Inducible nitricoxide synthase and nitric oxide production in human fetal astrocytes and microglia. J Biol Chem 1997; 272: 11327-35.
120. Bhat NR, Zhang P, Lee JC, Hogan EL. Extracellular signal-regulated kinase and p38 subgroups of MAPK regulate inducible nitric oxide synthase and TNF-α gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 1998; 18: 1633-41.
121. Lockhart BP, Cressey KC, Lepagnol JM. Suppression of nitric oxide formation by tyrosine kinase inhibitors in murine N9 microglia. Br J Pharmacol 1998; 123: 879-89.
122. Orskov I, Orskov F, Jann B, Jann K, Serology, chemistry and genetics of O and K antigens of Escherichia coli. Bacteriol Rev 1977; 41: 667-710.
123. Haber F, Weiss J. The catalytic decomposition of hydrogen peroxide by iron salts. Proc R Soc Lond A 1934; 147: 333-51.
124. Imlay JA, Linn S. DNA damage and oxygen radical toxicity. Science 1988; 240: 1302-9.
125. Beckman JS. Peroxynitrite versus hydroxyl radical: The role of nitric oxide in superoxide-dependent cerebral injury. Ann N Y Acad Sci. 1994; 738: 69-75.
126. Babior B. Oxidants from phagocytes: agents of defense and destruction. Blood 1984; 64: 959-66.
127. Neugebauer E, Lechleuthner A, Rixen D, Saad S. Pharmacotherapy of shock. In: Chernow B (ed). The Pharmacologic approach to the critically ill patient. Williams & Wilkins, 1994; 1104-21.
128. Weikert LF, Bernard GR. Pharmacotherapy of Sepsis. Clin Chest Med 1996; 289-305.
129. Galley HF, Howdle PD, Walker BE, Webster NR. The effects of intravenous antioxidants in patients with septic shock. Free Radic Biol Med 1997; 23: 768-74.
130. Pfister HW, Scheld WM. Brain injury in bacterial meningitis: therapeutic implications. Curr Opin Neurol 1997; 10: 254-9.
131. Frohlich L, Riederer P. Free radical mechanisms in dementia of Alzheimer type and potential for antioxidative treatment. Arzneimittelforschung 1995; 45: 443-6.
132. Mayer AMS, Spitzer JA: Modulation of superoxide anion generation by manoalide, arachidonic acid and staurosporine in liver infiltrated neutrophils in a rat model of endotoxemia. J Pharmacol Exp Ther 1993; 267: 400-9.
133. 2, protein serinethreonine phosphatases(s), protein tyrosine kinase(s) and phosphatase(s) inhibitors and arachidonic acid. J Pharmacol Exp Trier 1995; 274: 427-36.
134. 2. J Pharmacol Exp Ther 1996; 279: 633-44.
135. Heppner FL, Roth K, Nitsch R, Hailer NP. Vitamin E induces ramification and downregulation of adhesion molecules in cultured microglial cells. Glia 1998; 22. 180-8.
136. Mayer AMS, Oh S. Pharmacological targeting of signaling pathways in phorbol ester-stimulated superoxide generation in LPS-primed rat brain microglia. Soc Neurosci Abstr 1997; 23(2): 1443.
137. 2 production by Escherichia coli LPS-activated rat brain microglia. The Faseb J. 1998; 12(4): A461.